| Market Cap | 5.52B 4.83B 4.46B 4.16B 7.84B 521B 8.02B 53.65B 20.71B 257B 20.71B 20.26B 893B | P/E 2026 * |
50.5x | P/E 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.8B 6.83B 6.3B 5.89B 11.08B 737B 11.33B 75.85B 29.28B 364B 29.28B 28.64B 1,263B | EV / Sales 2026 * |
2.51x | EV / Sales 2027 * | 2.2x |
| Free-Float |
52.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Impax Laboratories Inc
| 1 day | -2.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 2019-07-31 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 2019-07-31 |
| Director of Finance/CFO | 58 | 2023-11-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 2023-11-06 |
J. Buchi
BRD | Director/Board Member | 70 | 2023-11-06 |
Jeffrey George
BRD | Director/Board Member | 52 | 2023-11-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -2.92% | - | - | 5.5B | ||
| +1.81% | +11.60% | +58.61% | +164.79% | 1,077B | ||
| +1.51% | +11.77% | +69.61% | +57.53% | 613B | ||
| +0.38% | +10.56% | +39.49% | +90.88% | 448B | ||
| +0.99% | +5.24% | +28.17% | +22.73% | 332B | ||
| -0.14% | +7.58% | +39.85% | +27.25% | 293B | ||
| -0.06% | +4.92% | +31.21% | +41.59% | 286B | ||
| -0.96% | +4.98% | -28.02% | -40.96% | 215B | ||
| +0.62% | +4.59% | +30.10% | +63.03% | 193B | ||
| -1.21% | +1.17% | +14.15% | +66.20% | 159B | ||
| Average | -0.06% | +7.46% | +31.46% | +54.78% | 401.79B | |
| Weighted average by Cap. | +0.65% | +9.11% | +43.00% | +81.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.11B 2.72B 2.51B 2.34B 4.41B 294B 4.51B 30.21B 11.66B 145B 11.66B 11.41B 503B | 3.33B 2.92B 2.69B 2.51B 4.73B 315B 4.84B 32.39B 12.5B 155B 12.5B 12.23B 539B |
| Net income | 113M 98.67M 91.09M 85.06M 160M 10.65B 164M 1.1B 423M 5.26B 423M 414M 18.25B | 270M 236M 218M 204M 383M 25.49B 392M 2.62B 1.01B 12.58B 1.01B 990M 43.66B |
| Net Debt | 2.28B 2B 1.84B 1.72B 3.24B 216B 3.32B 22.2B 8.57B 106B 8.57B 8.38B 370B | 1.8B 1.57B 1.45B 1.36B 2.56B 170B 2.61B 17.49B 6.75B 83.88B 6.75B 6.61B 291B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

















